Libo Pharma Corp. (TPEX:7888)
Taiwan · Delayed Price · Currency is TWD 39.35
-0.15 (-0.38%)
At close: May 29, 2026
Libo Pharma Market Cap
Libo Pharma has a market cap or net worth of 2.96 billion as of May 29, 2026.
Market Cap
2.96B
Enterprise Value
2.16B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
39.35
Market Cap Chart
Since December 23, 2025, Libo Pharma's market cap has decreased from 3.55B to 2.96B, a decrease of -16.54%. That is a compound annual growth rate of -34.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 2.96B | -20.02% |
| Dec 31, 2025 | 3.70B | 4.35% |
| Dec 23, 2025 | 3.55B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmasaga | 15.23B |
| TCM Biotech International | 9.00B |
| Taho Pharmaceuticals | 6.27B |
| Anbogen Therapeutics | 1.86B |
| TEH SENG Pharmaceutical Mfg. | 1.79B |
| Protect Animal Health | 1.76B |
| TSA International | 1.74B |
| Timing Pharmaceutial | 1.73B |